文献速递艾滋病与性传播感染病毒性肝炎

2001-2019年美国HIV感染者与非感染者肝细胞癌生存对比

Hepatocellular Carcinoma Survival in People With and Without HIV in the United States, 2001-2019.
PubMed 文献 · Clin Infect Dis · 2026-01-01

基于美国HIV/AIDS癌症匹配研究2001-2019年数据,纳入71 516例肝细胞癌(HCC)患者(含1610例HIV感染者),分析HIV对HCC特异性及全因死亡的影响。结果显示HIV与全因死亡风险升高34%相关(aHR 1.34),HCC特异性死亡风险轻度升高8%(aHR 1.08)。

要点

  • HIV感染者HCC全因死亡风险较非感染者高34%(aHR 1.34)。
  • HIV感染者HCC特异性死亡风险轻度升高8%(aHR 1.08)。
  • 未接受癌症治疗与男性、高龄均与HIV感染者HCC死亡风险升高相关。

核心结论

  • HIV感染与HCC患者全因死亡风险升高34%及HCC特异性死亡风险升高8%相关。

研究设计与样本

  • 基于美国HIV/AIDS癌症匹配研究,链接12个HIV与癌症登记处2001-2019年数据。
  • 纳入71 516例HCC患者,其中HIV感染者1610例,采用多变量校正Cox回归估计风险比。

主要发现

  • HIV感染者中1279例死亡,62.5%的死因为HCC。
  • HIV与全因死亡aHR 1.34(95%CI 1.27-1.41)及HCC特异性死亡aHR 1.08(95%CI 1.01-1.16)相关。
  • HIV感染者中,男性、HCC诊断时年龄较大及未接受癌症治疗与全因和HCC特异性死亡风险升高相关。
  • 与注射吸毒者相比,男男性行为者HCC特异性死亡风险升高。
  • 全因死亡风险从2001-2003年至2016-2019年下降(Ptrend < .0002),HCC特异性死亡风险下降趋势Ptrend = .06。

临床怎么用

  • HIV感染者HCC死亡风险更高,应重视HCC预防、筛查、诊断和治疗的机会。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Hepatocellular carcinoma (HCC) risk is elevated among people with human immunodeficiency virus (HIV) (PWH), but survival disparities are poorly understood. METHODS: We used data from the HIV/AIDS Cancer Match Study, a U.S. population-based linkage of 12 HIV and cancer registries during 2001-2019. Multivariable-adjusted Cox regression was used to estimate adjusted hazard ratios (aHRs) for HIV and HCC-specific and all-cause mortality among people with HCC, and to estimate aHRs for factors associated with HCC-specific and all-cause mortality among PWH. RESULTS: A total of 71 516 cases of HCC including 1610 PWH occurred during 2001-2019. Compared to people with HCC without HIV, a higher proportion of PWH were men, younger at time of cancer diagnosis, and were Black or Hispanic. Overall, 1279 deaths occurred among PWH (62.5% of deaths from HCC). HIV was associated with 34% higher all-cause mortality (aHR 1.34; 95% confidence interval, 1.27-1.41), and slightly increased HCC-specific mortality (aHR 1.08; 95% confidence interval, 1.01-1.16). Male sex, older age at HCC diagnosis, and nonreceipt of cancer treatment modalities were associated with increased all-cause and HCC-specific mortality among PWH. Increased HCC-specific mortality was also observed among men who have sex with men, compared to people who inject drugs. All-cause and HCC-specific mortality declined across calendar periods from 2001-2003 to 2016-2019 (Ptrends & .0002 and .06, respectively). CONCLUSIONS: HIV is associated with 34% higher all-cause and 8% higher HCC-specific mortality among PWH with HCC compared to those without HIV. As PWH are now living longer, and are at higher risk of HCC, research should prioritize opportunities for HCC prevention, screening, diagnosis, and treatment.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. McGee-Avila JK, Haas CB, Shing JZ, et al. Hepatocellular Carcinoma Survival in People With and Without HIV in the United States, 2001-2019. Clin Infect Dis. 2026. PMID: 41966980. doi:10.1093/cid/ciag137

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。